![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4152 | (2006.01) |
A61K 9/08 | (2006.01) | ||
A61K 9/20 | (2006.01) | ||
A61K 9/48 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61K 39/395 | (2006.01) |
(11) | Number of the document | 3216447 |
(13) | Kind of document | T |
(96) | European patent application number | 15857765.0 |
Date of filing the European patent application | 2015-11-05 | |
(97) | Date of publication of the European application | 2017-09-13 |
(45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2015/093837 |
Date | 2015-11-05 |
(87) | Number | WO 2016/070817 |
Date | 2016-05-12 |
(30) | Number | Date | Country code |
201410618300 | 2014-11-05 | CN |
(72) |
WANG, Yanjiang , CN
JIAO, Shusheng , CN
YAO, Xiuqing , CN
ZHOU, Xinfu , AU
|
(73) |
The Third Affiliated Hospital
Third Military Medical University, PLA ,
10 Changjiang Branch Road
Daping, Yuzhong District, Chongqing 400042,
CN
|
(54) | USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA) |
USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA) |